A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

Clinical trial NCT05256381 · TERMINATED

Trial details

NCT number: NCT05256381
Sponsor: SOTIO Biotech AG
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Colorectal Cancer Cutaneous Squamous Cell Carcinoma Hepatocellular Carcinoma Castration-resistant Prostate Cancer Ovarian Cancer

Start date: 2022-06-21
Primary completion: 2024-08-31
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.